Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  7.00 8.43% 90.00 89.00 90.00 89.50 83.50 83.50 1,945,229 16:35:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 9.8 1.2 0.8 112.5 162

Omega Diagnostics Share Discussion Threads

Showing 16126 to 16139 of 22200 messages
Chat Pages: Latest  648  647  646  645  644  643  642  641  640  639  638  637  Older
A LOT of really good stuff in that presentation, heres my take on what i heard. 1) profit from government is around 75p+. There is no additional profit share 2) profit from RTC antibody that is sold to non-government, there is an undisclosed additional profit share 3) Ramping up overall LFT capacity to 500K a week, and showed a path to 1M a week by Jan, and 2M a week by April. Of that, they are reserving 200K a week for gov RTC antibody orders. With a potential to eat into the overall capacity depending on additional gov requirement. CK appear to me to suggest that the 200K a week was the max that was covered by the "up to 25%" agreement, which suggests that it applies to an overall RTC order of 800K a week. Above that ODX would get 33% of additional orders. That was my take on what he said. 500K a week overall capacity is hoped to be able to be extended to 600K a week using the same equipment via optimisation of the processes. 4) The entire ramp up to a potential 2M a week can be acheived WITHIN existing funding, no new funding required. this was very clear. 5) Ramping up capacity to over 1M a week was not being done for the sake of it. That's paraphrasing but thats what he said. He also phrased things in such a way that I was left with the opinion that 200K a week from the Gov was a done deal. 6) I was the one that sent in the question in advance about whether there was an expectation that mass vaccination would require mass antibody testing, and he was very clear that it WAS his expectation. 7)Antigen LFT will hopefully be handed over to ODX by beginning of NOV. Would hope to be in a position to have completed 3 test runs by Xmas, or if not early in the new year. 8) As far as he is aware, the RTC test is the ONLY test that is being considered by MHRA, in other words at this time there are NO other antibody tests can have home use approval, or are being considered for home use approval. Expressed some disapointment that MHRA approval was not done at this time. Indicated that he would expect communication from MHRA very shortly, but that could be *possibly* a request for more information. 9) Spoke about targetting the US market for antibody (and I think antigen) testing. Said it was quite a bit of a process. They have someone working that angle for them, it includes getting FDA approval, but the suggestion was this could take quite a while. I sent a live question in relating to MHRA testing for Antigen LFT. Wanted to know if Home use would be a thing for LFT antigen, and whether having done it for antibody, if it would give them a head-start for Antigen MHRA, but that question didn't make the cut. There was a lot of stuff about their other businesses, such as HIV testing, and the food intolerance stuff, the summation of which is that both have a very positive outlook. I felt the facts and outlook was really great, his presentation is a bit stumbling, the finanacial guy is a more assured presenter. I was left feeling that the formal RNS was a missed opportunity as the presentation provided outlook that could been in the RNS.
Aiming for 2 million on the chart but was bullish that with a few tweaks for efficiencies could see 2.5 million. Don't need that level of capacity unless confident orders will follow.
barrywhit he did say 2.5 million a week and has sufficient funds to do it. If anyone needed to know how this could also be a £5.00 a share they had it spelt out today for certain. Welldone ODX....There is only one downside we have the idiots on the board!!!
Expect a bounce tomorrow, all looking very good.
Barrywhit it is 2m and rising. All seriously good at ODX and the Antibody Elisa hiccup frees space for more of the lateral flow testing (both antibody and antigen) which, along with RTC is where the Covid opportunities are. And do not forget: Visetect CD4 is major league in play & Food intolerance testing and China will be huge
I couldn't log in directly, but read the key points that posters posted on lse. So once again thanks to them. Inmv I cannot see what more the ceo and his team can do. Its a shame that market turmoil may hold the share price back in the short term.
There will be a recording of the Presentation you can listen to added to the website shortly...
Yes and in summary it was all very positive. Check out lse boards.
Did anyone listen to the webcast presentation?any info from it? Tia
19:00 I thought Colin said gearing up to 2.5 million a week but i may have got that wrong....but NO PLACING REQUIRED........
Was hoping for better but this share chart has characters worthy of a cess pit. You know who you are. All the others speaking sense, that filter button must be used frequently!
tricky red
I left the other #ODX BB because of these clowns.Now they're here !
“X KING OF TAJ MAHAL” 👑 HAHAHAHAHHA HAHAHAHAH HAHAHAHHA SPECIALIST. 👅 (;) (.) (.) specialists mummy I love ya baby
Chat Pages: Latest  648  647  646  645  644  643  642  641  640  639  638  637  Older
ADVFN Advertorial
Your Recent History
Omega Diag..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210302 04:49:05